Deadly dengue fever impacts climate-hit Bangladesh coast
Mosquito-borne dengue fever was rarely a major problem in Bangladesh's coastal districts, but some hospitals are so full of those with the potentially deadly virus that patients are treated on the floor.
As climate change drives erratic weather patterns, experts point to a dire lack of clean drinking water in the wider delta -- where the snaking Brahmaputra and Ganges rivers reach the sea -- as a likely driving force for the surge.
Rakibul Islam Rajan said his two-year-old daughter keeps searching for her mother, Azmeri Mona Lisa Zareen, who died of dengue in early June in the southern region of Barisal.
"Zareen developed high fever... her blood pressure collapsed -- and then she couldn't breathe," said 31-year-old Rajan.
"Our daughter keeps searching for her from one room to another".
In the worst cases, intense viral fevers trigger bleeding, internally or from the mouth and nose.
Barisal has recorded nearly half of the 7,500 dengue cases across Bangladesh this year, according to the Institute of Epidemiology, Disease Control and Research (IEDCR).
Five people have died there this year with dengue fever, out of 31 deaths recorded across the entire country of some 170 million people.
Numbers are still far below the deadly outbreak of 2023, when more than 1,700 people died across the South Asian nation, and more than 200,000 were infected.
In the Barisal district of Barguna, the hospital is packed full.
Barisal health chief Shyamol Krishna Mondal said it was the "worst we've seen".
Barguna's 250-bed public hospital was coping with more than 200 dengue patients.
"We couldn't even offer beds," Mondal said. "They are getting treatment while lying on the floor."
Kabirul Bashar, an expert on disease at Jahangirnagar University, said a lack of clean water was "one of the major reasons".
People store rainwater in containers, exactly the conditions mosquitoes love.
"The water distribution system is almost absent," Bashar said.
- 'Vulnerability is soaring' -
While a lack of clean water is a long-running problem, climate change is making it worse.
Rising seas driven by climate change threaten swathes of low-lying Bangladesh, with increasing numbers of powerful storms bringing seawater further inland, turning wells and lakes salty, according to government scientists.
Changing weather patterns, making once predictable rains uncertain, adds to the challenge -- with people storing rainwater when they can.
But Mushtuq Husain, a public health expert and adviser at IEDCR, said that the plentiful water storage pots also provided perfect mosquito breeding sites.
"We can't allow water stagnation anywhere -- that should be the rule of thumb, but it's not happening," he said.
"The vulnerability is soaring because of the high temperatures and erratic rainfall, which are conducive to mosquito breeding."
Bangladesh has recorded cases of dengue since the 1960s but documented its first outbreak of dengue haemorrhagic fever, a severe and sometimes fatal form of the disease, in 2000.
The World Health Organization (WHO) has warned that dengue and other mosquito-borne viruses are spreading faster and further due to climate change.
About half of the world's population is now at risk of dengue, with an estimated 100 to 400 million infections occurring each year, and many of those causing only mild illness, according to the WHO.
Rajan, mourning his wife, worries that there will be more deaths to come, accusing local authorities of failing to stem mosquitoes.
"Dengue has taken her," he said of his late wife. "I don't know how many more are in the queue... but I don't see enough cleanup activities."
sa/rsc/pjm/jfx
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Deadly dengue fever impacts climate-hit Bangladesh coast
Mosquito-borne dengue fever was rarely a major problem in Bangladesh's coastal districts, but some hospitals are so full of those with the potentially deadly virus that patients are treated on the floor. As climate change drives erratic weather patterns, experts point to a dire lack of clean drinking water in the wider delta -- where the snaking Brahmaputra and Ganges rivers reach the sea -- as a likely driving force for the surge. Rakibul Islam Rajan said his two-year-old daughter keeps searching for her mother, Azmeri Mona Lisa Zareen, who died of dengue in early June in the southern region of Barisal. "Zareen developed high fever... her blood pressure collapsed -- and then she couldn't breathe," said 31-year-old Rajan. "Our daughter keeps searching for her from one room to another". In the worst cases, intense viral fevers trigger bleeding, internally or from the mouth and nose. Barisal has recorded nearly half of the 7,500 dengue cases across Bangladesh this year, according to the Institute of Epidemiology, Disease Control and Research (IEDCR). Five people have died there this year with dengue fever, out of 31 deaths recorded across the entire country of some 170 million people. Numbers are still far below the deadly outbreak of 2023, when more than 1,700 people died across the South Asian nation, and more than 200,000 were infected. In the Barisal district of Barguna, the hospital is packed full. Barisal health chief Shyamol Krishna Mondal said it was the "worst we've seen". Barguna's 250-bed public hospital was coping with more than 200 dengue patients. "We couldn't even offer beds," Mondal said. "They are getting treatment while lying on the floor." Kabirul Bashar, an expert on disease at Jahangirnagar University, said a lack of clean water was "one of the major reasons". People store rainwater in containers, exactly the conditions mosquitoes love. "The water distribution system is almost absent," Bashar said. - 'Vulnerability is soaring' - While a lack of clean water is a long-running problem, climate change is making it worse. Rising seas driven by climate change threaten swathes of low-lying Bangladesh, with increasing numbers of powerful storms bringing seawater further inland, turning wells and lakes salty, according to government scientists. Changing weather patterns, making once predictable rains uncertain, adds to the challenge -- with people storing rainwater when they can. But Mushtuq Husain, a public health expert and adviser at IEDCR, said that the plentiful water storage pots also provided perfect mosquito breeding sites. "We can't allow water stagnation anywhere -- that should be the rule of thumb, but it's not happening," he said. "The vulnerability is soaring because of the high temperatures and erratic rainfall, which are conducive to mosquito breeding." Bangladesh has recorded cases of dengue since the 1960s but documented its first outbreak of dengue haemorrhagic fever, a severe and sometimes fatal form of the disease, in 2000. The World Health Organization (WHO) has warned that dengue and other mosquito-borne viruses are spreading faster and further due to climate change. About half of the world's population is now at risk of dengue, with an estimated 100 to 400 million infections occurring each year, and many of those causing only mild illness, according to the WHO. Rajan, mourning his wife, worries that there will be more deaths to come, accusing local authorities of failing to stem mosquitoes. "Dengue has taken her," he said of his late wife. "I don't know how many more are in the queue... but I don't see enough cleanup activities." sa/rsc/pjm/jfx
Yahoo
2 days ago
- Yahoo
Mounjaro becomes available on the NHS: what to know and what to do if you're not eligible
Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it. It affects nearly every organ system in the body, contributing to cardiovascular conditions like coronary heart disease; musculoskeletal issues such as osteoarthritis and gout; and even the development of certain cancers, including of the breast, uterus and colon. Its impact on mental health is also significant. A few years ago, injectable weight-loss drugs entered clinical use and quickly captured public attention for their ability to promote rapid fat loss. Ozempic is available on the NHS, but only for managing type 2 diabetes. Wegovy is authorised for weight loss and cardiovascular risk reduction and is also available on the NHS, though access is currently limited to specialist weight management services. Now, a new option has emerged: Mounjaro, which is approved for both type 2 diabetes and weight loss. This dual-purpose drug is now available on the NHS, offering another potential tool in the fight against obesity. Demand is expected to be high. However, access will be limited at first, with strict eligibility criteria for NHS prescriptions. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. Mounjaro (tirzepatide) is a once weekly injectable medication designed to help control blood-sugar levels. It works by boosting the secretion and effects of insulin, improving glycaemic control in people with Type 2 diabetes. It also slows gastric emptying — the process by which food leaves the stomach — and enhances feelings of fullness by acting on the brain. This combined effect reduces appetite and helps support weight loss. Compared to similar medications like Ozempic and Wegovy (both brand names for semaglutide), clinical trials found Mounjaro more effective, with some participants losing up to 20% of their body weight over a 72-week period. Read more: The NHS has introduced specific criteria to prioritise patients most in need. First, patients need a BMI of 40 or more (classified as morbid obesity). People from certain ethnic backgrounds, such as South Asian communities, may be eligible at a lower BMI due to higher clinical risk of health conditions. Second, at least four obesity-related health conditions must be diagnosed, including type 2 diabetes, hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol or triglyceride levels), cardiovascular disease and obstructive sleep apnoea. (Some of these conditions often occur together; for example, high blood pressure and cholesterol.) Patients are encouraged to check their BMI and confirm their diagnoses before contacting a GP. This helps ensure appointments are used effectively and discussions remain focused. While the current criteria are strict, there is optimism that eligibility will broaden in the coming years to include people with lower BMIs and fewer co-morbidities. The NHS continues to offer a comprehensive weight-loss programme, tiered according to BMI and previous attempts at weight loss. Don't underestimate the value of group-based programmes or community referrals – when a healthcare professional refers a patient to a community-based health service for further care or support – many of which can be accessed via your GP. These services, such as the NHS digital weight management programme, support both individuals and families and can be highly effective for sustainable fat loss. GPs may also refer patients to online courses and structured exercise programmes. Lifestyle interventions, including increased physical activity and healthier eating, remain cornerstones of obesity treatment and are critical for long-term success, even when medications are used. Read more: Higher tier interventions may be considered if lifestyle changes fail or if the patient has significant co-morbidities. This is where medications like Mounjaro, or private prescriptions, may become relevant – albeit that the cost of the latter may be a limiting factor for some. Other treatments include Orlistat, a medication that reduces fat absorption in the gut. This can be effective for some but often causes unpleasant side effects, such as oily stools and gastrointestinal upset Gastric banding or surgery may also result in significant, sustained weight loss, but they come with risks, can lead to surgical complications, and recovery can be demanding It's also important to recognise that drugs like Mounjaro aren't suitable for everyone. They can cause side effects significant enough for people to stop using them, and in some cases, they may not work at all. In this new era of faster, medication-assisted weight loss, we must remember that long-term change is about more than quick fixes. Sustainable success comes from consistent effort, willingness to change and methods that are both practical and lasting. Medications can help, sometimes dramatically, but they're not the only answer. A return to basics, with tailored support and realistic goals, remains as relevant as ever. So whether you qualify for Mounjaro, are trying lifestyle changes, or are exploring other options, remember this: the journey to better health is personal, gradual and worth it. This article is republished from The Conversation under a Creative Commons license. Read the original article. Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Yahoo
08-06-2025
- Yahoo
Women less likely to get life-saving care for deadly heart condition
A new analysis reveals that women are less likely than men to receive treatment for aortic stenosis, a potentially fatal heart condition. Researchers discovered that women are 11% less likely to be referred to a hospital specialist following a diagnosis of the heart valve disease. Academics noted that the findings reveal "inequities in management and care of this common and serious condition." The study also found differences in care among south Asian and black patients, as well as those from poorer backgrounds. Aortic stenosis, a narrowing of the aortic valve or the area immediately around it, leads to obstruction of the blood flow from the heart, which leads to symptoms including dizziness, fatigue, chest pain and breathlessness. The condition is more common in elderly people. It is not possible to reverse but treatments can include a transcatheter aortic valve implantation (TAVI) or valve replacement surgery. If left untreated it can lead to serious complications, including heart failure, heart rhythm abnormalities, and death. The analysis suggests some people are less likely to receive this treatment. Experts from the University of Leicester examined GP data on 155,000 people diagnosed with aortic stenosis between 2000 and 2022 in England. Presenting their findings to the British Cardiovascular Society conference in Manchester, experts said as well as women being less likely to be referred for hospital care, they are 39% less likely to have a procedure to replace their aortic valve. Researchers also found people living in poorer neighbourhoods are 7% less likely to be referred for hospital care after a diagnosis compared to people from wealthier neighbourhoods. Meanwhile, black patients are 48% less likely to undergo a procedure to replace their aortic valve compared to white patients. South Asian patients are 27% less likely to undergo a procedure compared to their white counterparts, according to the study, which was funded by the National Institute for Health and Care Research (NIHR) and supported by NIHR Leicester Biomedical Research Centre. Dr Anvesha Singh, associate professor at the University of Leicester and consultant cardiologist, who was involved in the research, said: 'Previous studies have shown lower rates of valve replacement in women, and clinicians had assumed that women were less likely to be diagnosed with aortic stenosis. 'This analysis using large, real-world data clearly shows that this is not the case, giving us the clearest picture yet of what is happening in day-to-day clinical practice. 'Our study highlights potential inequities in management and care of this common and serious condition. More research is needed to understand the reasons for this and the true prevalence of aortic stenosis in different groups.' Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation, which supported the research, and consultant cardiologist, said: 'This study of over 150,000 GP records has unveiled disparities in access to aortic valve treatment for women, south Asian and black people, and people living in more deprived communities. 'We don't yet have the full picture, but these findings are concerning and we need more research to understand what is driving the differences seen. 'This will be crucial to enable action to address any underlying causes stopping some people from having access to the heart valve treatment and care they need, when they need it.'